Laurus Labs has reported results for third quarter ended December 31, 2022.
The company has reported rise of 82.35% in its net profit at Rs 199.05 crore for Q3FY23 as compared to Rs 109.16 crore for the corresponding quarter previous year. Total income of the company increased by 60.01% to Rs 1,503.68 crore for the quarter under review as compared to Rs 939.77 crore for the same quarter in the previous year.
On the consolidated basis, the company has reported rise of 31.03% in its net profit at Rs 203.06 crore for Q3FY23 as compared to Rs 154.97 crore for the same quarter in the previous year. Total income of the company increased by 49.53% to Rs 1,546.25 crore for the quarter under review as compared to Rs 1,034.09 crore for the same quarter in the previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1504.25 |
Dr. Reddys Lab | 6263.70 |
Cipla | 1406.25 |
Zydus Lifesciences | 948.20 |
Lupin | 1615.85 |
View more.. |